Up to a quarter of patients with certain chronic recalcitrant tendinopathies may have central sensitisation: a prospective cohort of more than 300 patients
Restricted accessResearch articleFirst published online August, 2019
Up to a quarter of patients with certain chronic recalcitrant tendinopathies may have central sensitisation: a prospective cohort of more than 300 patients
To identify the possible prevalence of ‘central sensitisation’, in patients with chronic recalcitrant lower limb tendinopathy conditions, with the Central Sensitisation Inventory (CSI) questionnaire.
Methods:
Patients with chronic lower limb tendinopathy conditions treated within a single hospital outpatient clinic specialising in tendinopathy were identified from clinical records. As part of routine care, self-reported numerical markers of pain, global function (using the EuroQol-5D (EQ-5D) questionnaire) and the CSI score to investigate the possibility of central sensitisation were completed.
Results:
A total of 312 suitable patients with chronic lower limb tendinopathy and similar conditions were identified, who had completed a CSI questionnaire. Of these, 108 presented with greater trochanteric pain syndrome, 12 with patella tendinopathy, 33 with non-insertional Achilles tendinopathy, 48 with insertional Achilles tendinopathy and 110 with plantar fasciitis. A total of 66% of the patients were female, the median age was 54.9 years and the median duration of symptoms was 24 months. There was a median CSI score of 25%, with statistically significant differences noted between the different conditions studied. Overall, 20% of patients scored above a threshold of 40% on CSI questionnaire, indicating that central sensitisation was possible. Greater trochanteric pain syndrome and plantar fasciitis had the highest proportions in the conditions studied. Weak correlations were found between CSI and other pain scores studied.
Conclusion:
The CSI questionnaire may identify up to a quarter of patients with some chronic lower limb tendinopathy and associated conditions as being more likely to have central sensitisation, and these proportions differed between conditions. The clinical significance of this is unclear, but worth further study to see if/how this may relate to treatment outcomes. These are results from a single hospital clinic dealing with patients with chronic tendinopathy, and comparison with a control group is currently lacking. However, on the information presented here, the concept of central sensitisation should be considered in patients being treated for chronic tendinopathy.
PaavolaMKannusPPaakkalaTet al. Long-term prognosis of patients with Achilles tendinopathy: an observational 8-year follow-up study. Am J Sports Med2000; 28(5): 634–642.
2.
LievenseABierma-ZeinstraSSchoutenBet al. Prognosis of trochanteric pain in primary care. Br J Gen Pract2005; 55(512): 199–204.
3.
DiGiovanniBFNawoczenskiDALintalMEet al. Tissue-specific plantar fascia-stretching exercise enhances outcomes in patients with chronic heel pain. A prospective, randomized study. J Bone Joint Surg Am2003; 85-A(7): 1270–1277.
4.
KindlerLLBennettRMJonesKD.Central sensitivity syndromes: mounting pathophysiologic evidence to link fibromyalgia with other common chronic pain disorders. Pain Manag Nurs2011; 12(1): 15–24.
5.
HolmLWCarrollLJCassidyJDet al. Widespread pain following whiplash-associated disorders: incidence, course, and risk factors. J Rheumatol2007; 34(1): 193–200.
6.
AggarwalVRMcBethJZakrzewskaJMet al. The epidemiology of chronic syndromes that are frequently unexplained: do they have common associated factors?Int J Epidemiol2006; 35(2): 468–476.
7.
NijsJTorres-CuecoRvan WilgenPet al. Applying modern pain neuroscience in clinical practice: criteria for the classification of central sensitization pain. Pain Physician2014; 17(5): 447–457.
8.
LluchETorresRNijsJet al. Evidence for central sensitization in patients with osteoarthritis pain: a systematic literature review. Eur J Pain2014; 18: 1367–1375.
9.
MayerTGNeblettRCohenHet al. The development and psychometric validation of the Central Sensitization Inventory. Pain Pract2012; 12(4): 276–285.
10.
NeblettRCohenHChoiYet al. The Central Sensitization Inventory (CSI): establishing clinically significant values for identifying central sensitivity syndromes in an outpatient chronic pain sample. J Pain2013; 14(5): 438–445.
11.
NeblettRHartzellMMCohenHet al. Ability of the Central Sensitization Inventory to identify central sensitivity syndromes in an outpatient chronic pain sample. Clin J Pain2015; 31(4): 323–332.
12.
AlfredsonHCookJL.A treatment algorithm for managing Achilles tendinopathy: new treatment options. Br J Sports Med2007; 41(4): 211–216.
13.
CookJLPurdamC.Is compressive load a factor in the development of tendinopathy?Br J Sports Med2012; 46(3): 163–168.
14.
CookJLKhanKM.What is the most appropriate treatment for patellar tendinopathy?Br J Sports Med2001; 35(5): 291–294.
15.
PeersKELysensRJ.Patellar tendinopathy in athletes: current diagnostic and therapeutic recommendations. Sports Med2005; 35(1): 71–87.
16.
HellandCBojsen-MøllerJRaastadTet al. Mechanical properties of the patellar tendon in elite volleyball players with and without patellar tendinopathy. Br J Sports Med2013; 47(13): 862–868.
17.
SharmaPMaffulliN.Tendon injury and tendinopathy: healing and repair. J Bone Joint Surg Am2005; 87(1): 187–202.
18.
CookJLPurdamCR.Is tendon pathology a continuum? A pathology model to explain the clinical presentation of load-induced tendinopathy. Br J Sports Med2009; 43(6): 409–416.
19.
WilliamsBSCohenSP.Greater trochanteric pain syndrome: a review of anatomy, diagnosis and treatment. Anesth Analg2009; 108(5): 1662–1670.
20.
Kingzett-TaylorATirmanPFFellerJet al. Tendinosis and tears of gluteus medius and minimus muscles as a cause of hip pain: MR imaging findings. Am J Roentgenol1999; 173(4): 1123–1126.
21.
SilvaFAdamsTFeinsteinJet al. Trochanteric bursitis: refuting the myth of inflammation. J Clin Rheumatol2008; 14(2): 82–86.
22.
SteccoCCorradinMMacchiVet al. Plantar fascia anatomy and its relationship with Achilles tendon and paratenon. J Anat2013; 223(6): 665–676.
23.
LemontHAmmiratiKMUsenN.Plantar fasciitis: a degenerative process (fasciosis) without inflammation. J Am Podiatr Med Assoc2003; 93(3): 234–237.
24.
DrewBTSmithTOLittlewoodCet al. Do structural changes (eg, collagen/matrix) explain the response to therapeutic exercises in tendinopathy: a systematic review. Br J Sports Med2014; 48: 966–972.
25.
RathleffMSThorborgK.‘Load me up, Scotty’: mechanotherapy for plantar fasciopathy (formerly known as plantar fasciitis). Br J Sports Med2015; 49: 638–639.
26.
OrchardJ.Plantar fasciitis. BMJ2012; 345: e6603.
27.
De JongeSvan den BergCde VosRJet al. Incidence of midportion Achilles tendinopathy in the general population. Br J Sports Med2011; 45(13): 1026–1028.
28.
RompeJDSegalNACacchioAet al. Home training, local corticosteroid injection, or radial shock wave therapy for greater trochanter pain syndrome. Am J Sports Med2009; 37(10): 1981–1990.
29.
BuchbinderR.Plantar fasciitis. New Engl J Med2004; 350(21): 2159–2166.
30.
AlfredsonH.Chronic midportion Achilles tendinopathy: an update on research and treatment. Clin Sports Med2003; 22(4): 727–741.
31.
LianØBEngebretsenLBahrR. Prevalence of jumper’s knee among elite athletes from different sports: a cross-sectional study. Am J Sports Med2005; 33(4): 561–567.
32.
CookJLKhanKMHarcourtPRet al. A cross sectional study of 100 athletes with jumper’s knee managed conservatively and surgically. The Victorian Institute of Sport Tendon Study Group. Br J Sports Med1997; 31(4): 332–336.
33.
AbateMSilbernagelKGSiljeholmCet al. Pathogenesis of tendinopathies: inflammation or degeneration?Arthritis Res Ther2009; 11: 235.
34.
RioEMoseleyLPurdamCet al. The pain of tendinopathy: physiological or pathophysiological?Sports Med2014; 44(1): 9–23.
35.
D’AddonaAMaffulliNFormisanoSet al. Inflammation in tendinopathy. Surgeon2017; 15(5): 297–302.
36.
MillarNLMurrellGACMcInnesIB.Inflammatory mechanisms in tendinopathy – towards translation. Nat Rev Rheumatol2017; 13: 110–122.
37.
LeeWCCWongWYKungEet al. Effectiveness of adjustable dorsiflexion night splint in combination with accommodative foot orthosis on plantar fasciitis. J Rehabil Res Dev2012; 49(10): 1557–1564.
38.
WheelerPC.The effectiveness and tolerability of tension night splints for patients with chronic plantar fasciitis – a case-series study. Int Musculoskelet Med2014; 36(4): 130–136.
WheelerPC.The addition of a Tension Night Splint to a structured home rehabilitation programme in patients with chronic plantar fasciitis does not lead to significant additional benefits in either pain, function or flexibility: a single-blinded randomised controlled trial. BMJ Open Sport Exerc Med2017; 3: e000234.
41.
WheelerPC.The use of high-volume image-guided injections (HVIGI) for Achilles tendinopathy – a case series & pilot study. Int Musculoskelet Med2014; 36(3): 96–103.
42.
WheelerPCMahadevanDBhattRet al. A comparison of two different high-volume image-guided injection procedures for patients with chronic non-insertional Achilles tendinopathy: a pragmatic retrospective cohort study. J Foot Ankle Surg2016; 55(5): 976–979.
43.
WheelerPC.Autologous blood injections for chronic plantar fasciitis – a pilot case-series study shows promising results. Int Musculoskelet Med2013; 35(1): 3–7.
44.
GrossCEHsuARChahalJet al. Injectable treatments for noninsertional Achilles tendinosis: a systematic review. Foot Ankle Int2013; 34(5): 619–628.
45.
WheelerPC.The role of autologous blood injections in the treatment for patients with chronic plantar fasciitis – a case series and longer term follow-up. Int Musculoskelet Med2015; 37(2): 47–53.
46.
Mani-BabuSMorrisseyDWaughCet al. The effectiveness of extracorporeal shock wave therapy in lower limb tendinopathy: a systematic review. Am J Sports Med2015; 43(3): 752–761.
47.
WheelerPCTattersallC.The role of extra-corporeal shockwave therapy (ESWT) plus rehabilitation for patients with chronic greater trochanteric pain syndrome (GTPS), a case series assessing effects on pain, sleep quality, activity and functioning. Int Musculoskelet Med2016; 38(1): 27–35.
48.
WheelerPCTattersallC.Extracorporeal shockwave therapy plus rehabilitation for patients with chronic plantar fasciitis might reduce pain and improve function but still not lead to increased activity: a case-series study with multiple outcome measures. J Foot Ankle Surg2018; 57(2): 339–345.
49.
WheelerPCBoydKShiptonM.Surgery for patients with recalcitrant plantar fasciitis: good results at short-, medium-, and long-term follow-up. Orthop J Sport Med2014; 2(3): 2325967114527901.
50.
WiegerinckJIKerkhoffsGMvan SterkenburgMNet al. Treatment for insertional Achilles tendinopathy: a systematic review. Knee Surg Sport Tr A2013; 21(6): 1345–1355.
51.
VoosJERudzkiJRShindleMKet al. Arthroscopic anatomy and surgical techniques for peritrochanteric space disorders in the hip. Arthroscopy2007; 23(11): 1246.e1–1246.e5.
52.
WebbornADJ. Novel approaches to tendinopathy. Disabil Rehabil2008; 30(20–22): 1572–1577.
53.
AckermannPW.Neuronal regulation of tendon homoeostasis. Int J Exp Pathol2013; 94(4): 271–286.
54.
AlfredsonHÖhbergLForsgrenS.Is vasculo-neural ingrowth the cause of pain in chronic Achilles tendinosis? An investigation using ultrasonography and colour Doppler, immunohistochemistry, and diagnostic injections. Knee Surg Sport Tr A2003; 11(5): 334–338.
55.
AlfredsonHForsgrenSThorsenKet al. Glutamate NMDAR1 receptors localised to nerves in human Achilles tendons. Implications for treatment?Knee Surg Sport Tr A2001; 9(2): 123–126.
56.
SchubertTEOWeidlerCLerchKet al. Achilles tendinosis is associated with sprouting of substance P positive nerve fibres. Ann Rheum Dis2005; 64(7): 1083–1086.
57.
AlfredsonHLorentzonR.Chronic tendon pain: no signs of chemical inflammation but high concentrations of the neurotransmitter glutamate. Implications for treatment?Curr Drug Targets2002; 3(1): 43–54.
58.
WheelerPC.Neuropathic pain may be common in chronic lower limb tendinopathy: a prospective cohort study. Br J Pain2017; 11(1): 16–22.
59.
JanssenMFPickardASGolickiDet al. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study. Qual Life Res2013; 22(7): 1717–1727.
60.
HerdmanMGudexCLloydAet al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res2011; 20(10): 1727–1736.
